COVID-19: US FDA grants emergency authorisation for remdesivir
EUA doesn't equal final nod; China trial painted different picture
Suspect claims in Teva’s suit against Cipla
The US Federal Trade Commission has warned the Israeli drug firm its patents are wrongful as it sues Cipla aggressively